The FDA has updated guidance outlining how it applies regulatory flexibility to chemistry, manufacturing and control requirements for cell and gene therapies. The agency said the approach is meant to expedite development of complex biologics without compromising safety, purity or…
Pharmacy
CMS will implement lower maximum fair prices for 15 prescription drugs beginning Jan. 1, 2027. The drugs — which include treatments for cancer, Type 2 diabetes, asthma and chronic kidney disease — accounted for $42.5 billion, or 15%, of gross…